| scholarly article | Q13442814 |
| P50 | author | Stanley M Lemon | Q89119633 |
| P2093 | author name string | Masanori Ikeda | |
| Kui Li | |||
| MinKyung Yi | |||
| P2860 | cites work | Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein | Q24319002 |
| Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus | Q27469355 | ||
| Characterization of an autonomous subgenomic pestivirus RNA replicon | Q27469532 | ||
| Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase | Q27469720 | ||
| Characterization of cell lines carrying self-replicating hepatitis C virus RNAs | Q27469765 | ||
| Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation | Q27469769 | ||
| Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations | Q27469794 | ||
| Effect of alpha interferon on the hepatitis C virus replicon | Q27469963 | ||
| Subgenomic replicons of the flavivirus Kunjin: construction and applications | Q27480783 | ||
| Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee | Q27485872 | ||
| Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA | Q27860484 | ||
| Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
| Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line | Q27860561 | ||
| Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 | ||
| The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team | Q29619749 | ||
| Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection | Q29620702 | ||
| Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines. | Q33969067 | ||
| Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner | Q40801087 | ||
| The molecular virology of hepatitis C. | Q41499865 | ||
| An infectious molecular clone of a Japanese genotype 1b hepatitis C virus | Q42604623 | ||
| Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome | Q42616460 | ||
| Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection | Q43030456 | ||
| Hepatitis C Virus and Hepatocellular Carcinoma | Q71655577 | ||
| Natural history of hepatitis C | Q73717361 | ||
| P433 | issue | 6 | |
| P921 | main subject | virus | Q808 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| virology | Q7215 | ||
| P304 | page(s) | 2997-3006 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells | |
| P478 | volume | 76 |
| Q24550606 | 3' nontranslated RNA signals required for replication of hepatitis C virus RNA |
| Q45722093 | A model for the study of hepatitis C virus entry |
| Q58450547 | A new survival trick of hepatitis C virus: Blocking the activation of interferon regulatory factor-3 |
| Q35964872 | A primer on the molecular virology of hepatitis C. |
| Q27473360 | A promoter activity is present in the DNA sequence corresponding to the hepatitis C virus 5' UTR |
| Q39353241 | A twist in the tail: SHAPE mapping of long-range interactions and structural rearrangements of RNA elements involved in HCV replication. |
| Q40157434 | Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury |
| Q35702021 | Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells |
| Q26851652 | Advances in experimental systems to study hepatitis C virus in vitro and in vivo |
| Q42982177 | An adenine-to-guanine nucleotide change in the IRES SL-IV domain of picornavirus/hepatitis C chimeric viruses leads to a nonviable phenotype |
| Q33850594 | An in vitro model of hepatitis C virion production |
| Q40145225 | An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain |
| Q24316159 | Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector |
| Q24305035 | Antiviral activities of ISG20 in positive-strand RNA virus infections |
| Q27473083 | Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons |
| Q37832903 | Application of RNA interference in treating human diseases |
| Q42990432 | Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway |
| Q36026752 | Cell culture models and animal models of viral hepatitis. Part II: hepatitis C. |
| Q36841733 | Cell culture systems for the hepatitis C virus |
| Q40180818 | Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. |
| Q27472942 | Cell-free replication of the hepatitis C virus subgenomic replicon |
| Q24338259 | Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication |
| Q39629566 | Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein |
| Q33924891 | Chapter 20 Effects of hepatitis C core protein on mitochondrial electron transport and production of reactive oxygen species |
| Q27489695 | Characterization of Hepatitis C Virus Core Protein Multimerization and Membrane Envelopment: Revelation of a Cascade of Core-Membrane Interactions |
| Q40543432 | Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts |
| Q27473092 | Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs |
| Q38990872 | Cloning and expression of retinoic acid-induced gene-I and its effect on hepatitis C virus replication |
| Q42995221 | Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1). |
| Q36147887 | Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured Cells |
| Q27480270 | Comprehensive Analysis of the Effects of Ordinary Nutrients on Hepatitis C Virus RNA Replication in Cell Culture |
| Q27488265 | Consensus siRNA for inhibition of HCV genotype-4 replication |
| Q36942703 | Conserved C-terminal threonine of hepatitis C virus NS3 regulates autoproteolysis and prevents product inhibition |
| Q27473179 | Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras |
| Q40062488 | Construction of the Vero cell culture system that can produce infectious HCV particles |
| Q36760113 | Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry |
| Q29614206 | Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling |
| Q39734332 | Creation and characterization of a cell-death reporter cell line for hepatitis C virus infection |
| Q27486112 | Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection |
| Q37201846 | Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems |
| Q27491303 | Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A |
| Q36397553 | Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly |
| Q24609953 | DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation |
| Q27487022 | Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors |
| Q27490187 | Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening |
| Q27469439 | Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay. |
| Q34541863 | Different anti-HCV profiles of statins and their potential for combination therapy with interferon |
| Q24317623 | Direct interaction between nucleolin and hepatitis C virus NS5B |
| Q34792600 | Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation |
| Q43041362 | Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. |
| Q27473218 | Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication |
| Q27472746 | Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase |
| Q27472822 | Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression |
| Q27473141 | Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon |
| Q40584601 | Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon |
| Q37009852 | Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell |
| Q27473339 | Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture |
| Q39805946 | Efficient replication systems for hepatitis C virus using a new human hepatoma cell line |
| Q27490939 | Endocytic Rab proteins are required for hepatitis C virus replication complex formation |
| Q27473088 | Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection |
| Q31146715 | Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro |
| Q34544777 | Establishment of infectious HCV virion-producing cells with newly designed full-genome replicon RNA |
| Q53073025 | Eukaryotic translation initiation factor 4AII contributes to microRNA-122 regulation of hepatitis C virus replication. |
| Q34147312 | Evaluation of compound activity against hepatitis C virus in replicon systems |
| Q37713524 | Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee |
| Q37986051 | Exploitation of lipid components by viral and host proteins for hepatitis C virus infection |
| Q40560162 | Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. |
| Q43041152 | Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame |
| Q27473215 | Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes |
| Q28540849 | Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems |
| Q40584675 | Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells |
| Q97885926 | HCV Replicon Systems: Workhorses of Drug Discovery and Resistance |
| Q27488958 | Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C |
| Q37455000 | Hepatitis A virus (HAV) packaging size limit |
| Q27487110 | Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase |
| Q27473085 | Hepatitis C Virus F Protein Is a Short-Lived Protein Associated with the Endoplasmic Reticulum |
| Q27485880 | Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein |
| Q27473377 | Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2 |
| Q39635405 | Hepatitis C Virus: Propagation, Quantification, and Storage |
| Q35917417 | Hepatitis C drug discovery: in vitro and in vivo systems and drugs in the pipeline |
| Q38351589 | Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease |
| Q40344166 | Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes |
| Q57295205 | Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development |
| Q36326835 | Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture |
| Q24300748 | Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X |
| Q34235286 | Hepatitis C virus experimental model systems and antiviral drug research |
| Q24300002 | Hepatitis C virus expression suppresses interferon signaling by degrading STAT1 |
| Q40241920 | Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain |
| Q39523228 | Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis |
| Q42985608 | Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone |
| Q36749431 | Hepatitis C virus infection--pathobiology and implications for new therapeutic options |
| Q39241528 | Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy |
| Q34618241 | Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture |
| Q40636299 | Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication |
| Q42982521 | Hepatitis C virus replicons finally get to second base |
| Q27488905 | Hepatitis C virus replicons: dinosaurs still in business? |
| Q34988243 | Hepatitis C virus replicons: potential role for drug development |
| Q34970582 | Hepatitis C: molecular virology and antiviral targets |
| Q27490525 | Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA Replication |
| Q27469606 | Identification of Residues in the Hepatitis C Virus Core Protein That Are Critical for Capsid Assembly in a Cell-Free System |
| Q43049435 | Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase |
| Q34403294 | Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay |
| Q39349765 | Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA. |
| Q27473471 | Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons |
| Q36703045 | In vitro replication models for the hepatitis C virus |
| Q43041386 | Inducible system in human hepatoma cell lines for hepatitis C virus production |
| Q40408233 | Inhibition effect of Chinese herbal medicine on transcription of hepatitis C virus structural gene in vitro |
| Q24519072 | Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon |
| Q43031439 | Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model |
| Q40132466 | Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs |
| Q35565927 | Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies. |
| Q40469374 | Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine. |
| Q33204253 | Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes |
| Q34772253 | Interaction between hepatitis C virus proteins and host cell factors |
| Q35376259 | Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics |
| Q27473349 | Interference of hepatitis C virus RNA replication by short interfering RNAs |
| Q24814549 | Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinant |
| Q35072828 | Isolation and characterization of highly replicable hepatitis C virus genotype 1a strain HCV-RMT |
| Q36455986 | Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C. |
| Q27335708 | Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis |
| Q35669529 | Mechanisms of hepatitis C virus infection |
| Q27486435 | Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones |
| Q24653950 | Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms |
| Q36952835 | Modulation of host metabolism as a target of new antivirals |
| Q42984013 | Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell Culture |
| Q40882812 | Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro |
| Q40261915 | Mutations of the Hepatitis C virus protein NS4B on either side of the ER membrane affect the efficiency of subgenomic replicons |
| Q27473004 | Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees |
| Q45325110 | N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly |
| Q27683450 | NS2 Proteins of GB Virus B and Hepatitis C Virus Share Common Protease Activities and Membrane Topologies |
| Q26851159 | New hepatitis C virus drug discovery strategies and model systems |
| Q27477559 | Nonstructural Protein Precursor NS4A/B from Hepatitis C Virus Alters Function and Ultrastructure of Host Secretory Apparatus |
| Q40444001 | Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter |
| Q29620681 | Novel insights into hepatitis C virus replication and persistence |
| Q33582787 | Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis |
| Q38106964 | Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture |
| Q42994343 | Partial reconstitution of hepatitis C virus RNA polymerization by heterologous expression of NS5B polymerase and template RNA in bacterial cell |
| Q27480343 | Participation of Rab5, an Early Endosome Protein, in Hepatitis C Virus RNA Replication Machinery |
| Q35866290 | Permissiveness of human hepatoma cell lines for HCV infection |
| Q27473340 | Persistent Replication of Hepatitis C Virus Replicons Expressing the -Lactamase Reporter in Subpopulations of Highly Permissive Huh7 Cells |
| Q33700162 | Phosphate release contributes to the rate-limiting step for unwinding by an RNA helicase |
| Q24561987 | Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication |
| Q55190764 | Pluripotent Stem Cell-Derived Hepatocyte-like Cells: A Tool to Study Infectious Disease. |
| Q34576190 | Potential treatment options and future research to increase hepatitis C virus treatment response rate |
| Q41907539 | Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A |
| Q42980379 | Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor |
| Q27488616 | Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations |
| Q27477544 | Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells |
| Q27473106 | Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells |
| Q27860899 | Production of infectious hepatitis C virus in tissue culture from a cloned viral genome |
| Q40282946 | Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. |
| Q33337521 | Proteomic analysis of HuH-7 cells harboring in vitro-transcribed full-length hepatitis C virus 1b RNA. |
| Q38076055 | RNA interference--a silent but an efficient therapeutic tool |
| Q34621268 | RNAi therapeutics: principles, prospects and challenges |
| Q36811933 | Raloxifene inhibits hepatitis C virus infection and replication |
| Q36933791 | Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle |
| Q40273957 | Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture |
| Q29614208 | Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease |
| Q39842114 | Regulation of hepatitis C virus replication by the core protein through its interaction with viral RNA polymerase |
| Q35077458 | Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III. |
| Q35122644 | Regulatory mechanisms of viral hepatitis B and C |
| Q27477464 | Relationships between Hepatitis C Virus Replication and CXCL-8 Production In Vitro |
| Q27473475 | Replication Studies Using Genotype 1a Subgenomic Hepatitis C Virus Replicons |
| Q27477667 | Replication and IRES-Dependent Translation Are Both Affected by Core Coding Sequences in Subgenomic GB Virus B Replicons |
| Q27469483 | Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay |
| Q27477459 | Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities |
| Q27478415 | Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells |
| Q27477595 | Replication of a hepatitis C virus replicon clone in mouse cells |
| Q40459105 | Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells. |
| Q40438535 | Replication-competent chimeric hepatitis C virus subgenomic replicons |
| Q33910745 | Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein |
| Q37352979 | Retracted: Genetic diversity in hepatitis C virus (HCV): A brief review |
| Q27470013 | Robust hepatitis C virus infection in vitro |
| Q40436570 | Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication |
| Q27488384 | Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA |
| Q40113778 | Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. |
| Q40578897 | Sequence requirements for the development of a chimeric HCV replicon system |
| Q40176702 | Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication |
| Q27472765 | Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes |
| Q39148017 | Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. |
| Q38708263 | Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus |
| Q40243964 | Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication |
| Q27470232 | Stealth and cunning: hepatitis B and hepatitis C viruses |
| Q24540195 | Structure-function analysis of the 3' stem-loop of hepatitis C virus genomic RNA and its role in viral RNA replication |
| Q27481034 | Studying Hepatitis C Virus: Making the Best of a Bad Virus |
| Q27486946 | Subcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vector |
| Q40727114 | Subgenomic replicon derived from a cell line infected with the hepatitis C virus |
| Q40773451 | The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons. |
| Q36283505 | The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry |
| Q27481011 | The NS3 Helicase and NS5B-to-3'X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells |
| Q40505463 | The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities |
| Q27488207 | The NS4A Protein of Hepatitis C Virus Promotes RNA-Coupled ATP Hydrolysis by the NS3 Helicase |
| Q33719403 | The SR-BI partner PDZK1 facilitates hepatitis C virus entry. |
| Q24632380 | The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A |
| Q40078310 | The potential of signal peptide peptidase as a therapeutic target for hepatitis C. |
| Q34158687 | The rate of hepatitis C virus infection initiation in vitro is directly related to particle density. |
| Q37587437 | Therapeutic opportunities of small interfering RNA. |
| Q35105687 | Tissue culture and animal models for hepatitis C virus |
| Q24795677 | Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein |
| Q40350872 | Translational enhancement of HCV RNA genotype 1b by 3'-untranslated and envelope 2 protein-coding sequences |
| Q24800686 | Transmission of human hepatitis C virus from patients in secondary cells for long term culture |
| Q35576670 | Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. |
| Q37891074 | Turning hepatitis C into a real virus |
| Q30339086 | Unexpected host range of hepatitis C virus replicons. |
| Q38218108 | Unfolded protein response in hepatitis C virus infection |
| Q39756099 | Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly |
| Q34348958 | Unlocking the potential of the human genome with RNA interference |
| Q27473345 | Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture |
| Q24546318 | Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection |
| Q34568619 | Viral hepatitis and liver cancer: the case of hepatitis C. |
| Q28283814 | Viral reorganization of the secretory pathway generates distinct organelles for RNA replication |
| Q91767093 | Viral replicons as valuable tools for drug discovery |
| Q35544097 | Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis |
| Q27012614 | Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma |
| Q27473075 | Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins |
| Q40221698 | Zinc is a negative regulator of hepatitis C virus RNA replication. |
| Q40487547 | cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells |
| Q40178866 | p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells |
Search more.